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This article dealswith the questionhow to ensure that for newor existing business
activities in China, all legal aspects relating to technology commercialization and
knowledge transfer are taken into consideration.
For a valid IP strategy,an international companyneeds not only to analyze its own
IP position, but has also to look on the current Chinese patent legislation, i.e. the
way how Chinese companies act in this field and the specific regulations on
technology transfer from and into China.
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IP strategies in business operations with China
The first aspect - as far as ongoing changes
are concerned - refers to the amendments of
laws, regulations, guidelines, and case law of
the courts. This sets the legal framework for all
business operations in China, i.e. R&D work,
technology transfer into a joint venture,
marketing new products, or any mergers &
acquisitions.
The other aspect relevant for a valid IP
strategy relates to the IP activities of Chinese
companies.
Therefore, it is highly advisable to understand,
first, the position of Chinese authorities and, in
consequence, Chinese companies or other
entities before developing the own IP strategy.
Concerning the first aspect (amendments of
laws etc.), the third revision of the Chinese
Patent Law, effective on Oct. 1, 2009, is one
essential example. It clearly shows that since
1984, when the Chinese Patent Law has been
established, this law is constantly adjusted to
the actual needs and, in so doing, primarily of
the Chinese companies.
As to the IP activities of Chinese companies,
it is helpful to have a look on the Chinese patent
statistics. Following the above mentioned
“National IP Strategy”, Chinese companies are
very active in filing all kinds of IP applications
in China and abroad.
However, beyond of pure statistics, one can
also see a change in the Chinese “mind-set”. One
example is the statement by Nan Cunhui,
Chairman of Chint Group, a Chinese electronic
company, which sued Schneider, a French
electronic company, over IP infringement:
1 Introduction
“The competition of world’s future is the
competition of IP.”(Li and Jiang, 2012)
This statement made by Prime MinisterWen
Jiabao in 2010 indicates what China aims to
represent: An innovative country and no longer
just the “workbench of the world”. To make this
happen, China issued a “National IP Strategy”
on June 10, 2008 with the aim to “greatly
promote China’s capacity in creation, utilization,
protection, and administration of intellectual
property (IP)” (State Council of the People’s
Republic of China, 2008).
One important section within this National
IP Strategy is chapter V, 4, “Improving IP Law
Enforcement”, which is directed also towards
Chinese companies to enforce their rights
against third parties (State Council of the
People’s Republic of China, 2008).
In addition to this and to improve the IP
system further, China has issued a “National
Patent Development Strategy (2011 – 2020)”. In
view of China’s short history of establishing the
modern patent system, the government took
the position that some problems are remaining
and “the patent system has not become fully
integrated with the development of socialist
market economy” (citation from this Strategy).
Hence, for an international company, it is not
sufficient to develop an IP strategy for China
solely from its own perspective, but it rather
needs to take in consideration the ongoing
changes in China’s IP landscape, which have an
impact on a valid IP strategy.
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of the Chinese company needs to be analyzed
in detail.
To complete this picture, it is interesting to
notice that between January and October 2011,
IP rights civil cases received by the national
courts numbered 52,708 (an increase of 42% over
2010). This means that IP law enforcement is
getting more and more important. According
to the Supreme Peoples Court of China, among
the top ten IP cases for 2011 in the field of IP
infringement, there are only two patent cases
(related to an air conditioner and an antibiotic
composition), but four trademark disputes, two
copyright, and two unfair competition cases.
This clearly shows that in the total field of IP
right enforcement, patents (technical inventions)
are not as much in focus. So, copying famous
brands by Chinese companies is still the main
concern of non-Chinese companies.
3 IP strategy for a product covered by a
patent and designated for the Chinese
market
3.1 Working on the specifics
“Chinese companies are extremely efficient
at creating new versions of technologies and
products, often simpler, cheaper and more
effective, shortly after they are invented and
marketed elsewhere in the world.” (Comment
in China IP Report, June 20, 2012).
Although this sometimes might be a wishful
thinking, it nevertheless shows the approach
Chinese companies in principle follow. One
famous example is the above mentioned “fight”
between the electronic companies Chint and
Schneider over an infringement of Chint’s utility
model by Schneider, which resulted 2009 after
a “court mediated decision” in a payment of 157.5
million RMB (20.1 million Euro) by Schneider (as
a global settlement). Chint’s utility model was
only a small modification of the existing
technology, but has been held valid by the courts.
For chemical and pharmaceutical companies,
it is important to make sure that the above
mentioned “new versions”, which are usually
small modifications of the original invention,
must be covered by own patent applications or
utility models. At least they should be published
as a “defensive publication”, e.g. via internet
services, in order to make them prior art and to
avoid that Chinese companies are able to file
own IP rights on such modifications.
This means: Already during the internal
“I don’t mind how much Schneider pays us.
What I care about is winning the case. It will
help change the stereotype that it is Chinese
companies that are always accused in IPR cases.”
(Lu 2008)
2 What can we learn from Chinese IP
statistics?
The total number of patent applications with
the Chinese Patent Office (SIPO) in 2011 was
1,633,347 (including 526,412 inventions,
521,468 designs and 585,467 utility models) (total
number in 2010: 1,222,286). Only 21% of the
526,468 inventions in 2011 came from foreign
companies (This term “inventions” corresponds
to patent applications e.g. in Europe).  The shares
of foreign companies in the fields of Chinese
design- and utility model-applications are even
below 5% (according to SIPO statistics).
On the other hand, the numbers of patent
application with the European Patent Office
(EPO) submitted by Chinese companies soared
from 6,490 in 2009 to 12,698 in 2011. For
comparison: German companies filed
33,139 patent applications with EPO in 2011
(according to EPO statistics). 
In other words, this means:
Chinese companies are using their domestic
IP system to a greater extend than foreign
entities.
Before entering the Chinese market, a
company has to develop a freedom-to-
operate opinion, meaning an analysis of
possible IP rights in China which might block
or at least hinder its market activity in China.
The result of such an opinion has an
increasing impact on any own product or
project related IP strategy.
Even in Europe, patents owned by Chinese
companies might become relevant as a
market barrier. However, in the fields of
organic chemistry and pharmaceuticals, no
Chinese company can be found so far in the
list of the top 25 applicants with the EPO in
2011. For the time being, Chinese companies
focus on digital communications and similar
technical fields.
In case a Chinese company will be the target
for an acquisition by a non-Chinese company,
the innovative potential, i.e. the IP position
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said genetic resources shall be indicated in the
application. The applicant shall state reasons,
if he is unable to indicate the original source
(Art. 26).
So, before entering the Chinese market with
a specific product, it needs to be analyzed
whether or not there is a reasonable balance
between the possible IP protection for this
product and, on the other hand, the burden, e.g.
costs, for such a market launch in China.
4 R & D activities in China
Another category of business operations is the
establishment of a R&D center in China. There
are a lot of reasons which make it meaningful
to start an R&D center in China. Some of them
should be mentioned:
a)Tax incentives for high tech companies:
One essential point to achieve this high tech
status is the number of inventions made in China
(besides the number of employees in R&D and
other topics).
b)The “Hai Gui program” intended for high-
skilled returnees: In 2009, 63,300 young
professionals went back to China from abroad,
caused by the benefits of this program.
c)Biotechnology represents one of eight
technology fields of main interest defined by
state authorities. As a consequence, companies
filed 12,081 inventions patents in this field in
2011 (40% more than 2010), 77.7% of them owned
by Chinese companies.
d) In November 2008, China initiated the
Mega New Drug Development Program, funded
with more than 17 billion US-Dollars.
Irrespective of the importance of China as
market, it might be very interesting for a foreign
company to profit from this framework by
establishing an R&D center in China, either as
wholly owned Chinese affiliate or jointly with
a Chinese partner.
If a Chinese partner is involved, either within
a Joint Venture or as a co-operation partner, its
IP position should be clarified in advance: Do
the expected results stemming from such an
R&D activity depend on already existing patents
owned by the Chinese Partner? If so, it needs a
respective licensing contract from the early
beginning of such a co-operation as part of the
discussions with the inventor and before filing
the priority application, e.g. with the EPO, the
patent attorney has to think about possible
implications, if a future product covered by such
a priority application should be launched in
China, maybe years later. 
And it is not only about the small
modifications which need to be included, it is
also important from the very beginning to have
a good “coverage” for the patent claims in such
a priority application in terms of experiments
and working examples. To meet the requirement
of enablement (or “sufficiency of disclosure”) in
China (and to some extent also in Japan), it is
necessary that the original description already
discloses enough experimental evidence and
specific data to support the claims.
This is especially true for second medical use
inventions. It is not sufficient to provide a mere
written description of the use as claimed, but
it requires convincing efficacy data for such a
use in the initial application to prove that the
claimed invention can solve the targeted
problem. Clinical data, however, are not
necessary.
So, as always, professional and detailed work
in the very beginning sets the basis for a good
strategy.
3.2 Considering amended Chinese IP regulations
As already said, the Chinese patent law has
been revised  in 2010. Although this patent law
in general is in many aspects in line with, for
instance, the European patent law, there are
some amendments which might have an impact
on a product related IP strategy. 
Even if a company has filed a perfect patent
application covering an important e.g.
pharmaceutical product, one has to keep in mind
that the patent law now includes a Bolar
exemption (Art. 69, no patent infringement by
using e.g. a patented medication for gathering
data for administrative approval) without the
usual compensation by a patent term extension
(as it is the case in the US or Europe). And on
top of this, the compulsory license system is
rather favourable to generic companies: In case
a company does not “sufficiently” exploit its
patented product, a compulsory license might
be granted (Art. 48). So far, no specific examples
are known, but the “tool” exists anyway.
For biotech companies it is important to know
that for inventions which depend on genetic
resources the original and the direct source of
Andreas Bieberbach
Journal of Business Chemistry 2012, 9 (3)© 2012 Institute of Business Administration 164
in Chinese, sounds like the known “western”
trademark. One example is the “Rehau case”,
recently decided by the Shanghai No. 1
Intermediate Court. Rehau prevailed in a four
years trademark litigation and stopped Chinese
competitor Shanghai RUIHAO (!).
5.2 Enforcement of IP rights in China 
It is a “common understanding” (maybe
“misunderstanding”) that western companies
cannot enforce their IP rights in China because
of the weak legal system in China. According to
the “2012 China Business Climate Survey Report”
published by the American Chamber of
Commerce in China (AmCham China), 24% of
the respondents in the survey mentioned IP
rights infringement as a challenge (this seems
rather moderate in comparison to other
problems as management-level human resources
constraints with 43% and inconsistent regulatory
interpretation/unclear laws with 37%).
Nevertheless, only 34% of the respondents found
China’s IP right enforcement has improved.
However, one has to distinguish between
infringements of copyrights and designs, which
are still a big problem, but do not effect the
chemical industry so much as the consumer
industry, and patents, which are more important
in the field of chemistry and usually can be
enforced more effectively.
To be successful in enforcing patents, it is
essential to follow some “basic” rules:
a)Set up the right team of internal and
external experts and make sure that the
communication within the team is more than
just o.k.
b)Select the right venue. To avoid local
protectionism and have the case handled by an
IP experienced court, the choice of the right
court is important (Beijing or Shanghai are
recommended).
c)Select the right way of enforcement: In
principle, there are two ways of enforcement:
Administrative enforcement via the local
Administration for Industry and Commerce (AIC),
which is a Chinese speciality, and enforcement
via the court system (as it is known from Europe).
For complicated cases in the field of chemistry,
the court system maybe the preferred way.
d)Prepare the case very carefully and detailed.
The evidence presented before the court from
strategy.
Especially in the biotech field, there are
several interesting Chinese partners within the
Chinese Academy of Science for co-operations.
Just to name one of them: Shanghai Institute
for Biological Sciences (SIBS) has signed nine
patent licensing deals in 2011 worth more than
300 million RMB (ca. $46 million) according to
China Daily.
In any case, part of the organizational set up
for such an R&D activity and, consequently, of
an appropriate strategy, are IP contracts which
reflect the Chinese legal situation in a suitable
way. Mainly, three regulations need to be taken
into account in the first place:
1.Chinese universities as possible R&D
partners usually do not have a business license
and, therefore, are not allowed to sign a contract
with a foreign company. In such a situation, the
Chinese affiliate will be the right contractual
partner instead of the foreign parent company.
2. All inventions “made in China” within such
an R&D operation have to be filed with SIPO
first (Art. 20 of the Chinese Patent Law).
3.All contracts covering regulations on the
worldwide utilization of results stemming from
such R&D operation in China fall under the
Regulations of the People’s Republic of China
on Administration of the Import and Export of
Technology, effective from January 1, 2002
(“TIER”)
This shows that the necessary contractual
framework is complex and, therefore, should be
structured by an experienced attorney only.
5 Other important IP issues in China
In addition to the selected topics above, it is
necessary to consider a lot of other IP issues for
enterprises being active in China. Some of them
are mentioned below.
5.1 Trademarks and designs
Part of the “IP package” for a product in China
must be the right trademark and, if applicable,
a design patent. The own trademark, especially
in Chinese characters, is important, to make sure
that Chinese competitors may not entry as
copycats, not using the original trademark in
latin letters alphabet, but using  Chinese
characters as a trademark  which, pronounced
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purpose motors.” said an official according to
China IP Report of February 1, 2012 (Zhao, 2012).
If such an acquisition is a share deal (that
means the whole company will be bought), the
question of know how protection seems to be
obsolete. However, the IP professionals within
the targeted company should be very careful
during the due diligence process: In case the
deal fails (and nobody knows this in advance),
it is important that only those parts of the know
how are discovered during the due diligence
which are inevitably necessary for an assessment
of the value of the targeted company. In addition,
the disclosed parts should be clearly
documented.
If such a deal is an asset deal (that means
only parts of the business are transferred), it is,
in addition to the point made above, crucial that
there is a clear distinction between transferred
rights and rights which remain with the selling
company. If there are rights which are used by
both parties in the future, respective licensing
deals are necessary, covering also know how.
5.4 Lobbying 
Last but not least, it is very important for
European companies to be present in the
Chinese legal community. “Lobbying” in this
context does not mean trying to directly
influence, for instance, Chinese politicians, but
working in detail together with Chinese
authorities in order to improve the legal system.
China’s IP laws are still very “young” in
comparison to the western IP system and,
therefore, are still in an ongoing process of
improving and adopting the system to actual
needs.
Although this procedure is sometimes a little
bit frustrating, Chinese authorities are usually
open to accept comments and proposals and
discuss future amendments of the IP system
with all participants. Therefore, it is necessary
that western companies have established a
system of representation (e.g. chambers of
commerce in China, associations of
multinationals in China as the Quality Brand
Protection Committee, “QBPC”) which is able to
communicate with Chinese authorities. Such a
system, however, heavily depends on the
commitment of all the companies active in
China, including also the SME, not only the big
ones!
the very beginning is decisive!
e)Do not focus on the payment of possible
(but limited) damages, but try to stop
competitors in the first place.
In general, the proceeding before the Chinese
courts is all in all not longer than similar
litigations before German courts (one to two
years for one instance). In case, all evidence
(which means all necessary documents) is
presented to the court in the beginning of the
litigation, a Chinese court may decide within 6
months.
5.3 Know How protection 
From a Chinese point of view, the access to
high tech know how is one crucial point in the
process of making China an innovative country.
For an international company two  points need
to be considered: Legal and illegal transfer of
know how.
The legal “embodiment” is also known under
“forced technology transfer”, which means the
requirement of providing know how for market
access.
According to the above mentioned survey by
AmCham China, 67% of the respondents found
that such practices have a negative impact on
the assessment of the business environment in
China. However, if a company decides that the
Chinese market is important, it has to find a
way to deal with it. In practice, this entails a
detailed analysis of the situation, but there are
no simple answers to this problem.
The other point is the illegal “transfer” of
know how. There are a lot of measures to tackle
the problem, including “simple” protection of
the own premises or the own IT systems.
Avoiding an unreasonable fluctuation of the
personnel by an appropriate HR policy is another
issue. One important point, however, is again
the protection of the know how by effective and
enforceable (see above) IP rights.
In addition to this, there is a completely
different way for Chinese companies to get
access to relevant know how: Acquiring a
western company! One recent example is the
acquisition of the Italian luxury-yacht
manufacturer Ferretti by Shanghai Heavy
Industry Group, a 350 million Euro deal. “We now
own some hundreds of patents and rights to
use eight brands of Ferretti, which is very helpful
for improving our capacity in making general-
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6 Conclusion
In general, the development of an IP strategy,
especially for China, has to follow a holistic
approach. 
In a changing environment, such as the
Chinese IP system, it is not helpful to “rely” on
a perpetual prejudice and to ignore
opportunities, provided by such a changing
system. During the last years, it becomes very
clear that more and more Chinese companies
use the Chinese patent system, not only by filing
patent applications as can be seen from the
statistics above, but also by starting IP litigations
against other Chinese (and foreign!) companies.
This will certainly lead to a further development
of the Chinese IP system. So far the visible
development is rather similar to what we know
from the European IP system.
Therefore, it is crucial to keep two things in
mind:
a)Setting up an internal IP structure and
network appropriate to the needs of a company,
which can serve as the basic for all IP work in
China.
b)Developing a product- and/or project-
specific IP strategy, which includes all aspects
of possible IP protection.
Of course, this approach is not for free, but
as always, sustainable operations need a
permanent commitment.
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